NF155+ CIDP patients showed a higher frequency of distal acquired demyelinating symmetric neuropathy (DADS) than NF155− CIDP patients (P = 0.0013), although more than half of NF155+ CIDP patients (57.1%) had typical CIDP. This evidence concerns the gene PMP22 and chronic inflammatory demyelinating polyradiculoneuropathy.